Valuation: MEDADVISO

Market Cap 7.65M 5.35M 4.69M 4.35M 4M 7.53M 516M 51.84M 20.29M 253M 20.08M 19.65M 873M P/E 2024
385x
P/E 2025 -0.76x
Enterprise Value 14.74M 10.31M 9.04M 8.39M 7.71M 14.52M 995M 99.92M 39.11M 487M 38.71M 37.88M 1.68B EV / Sales 2024
2.23x
EV / Sales 2025 0.92x
Free-Float
61.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 46 2025-11-06
Director of Finance/CFO - 2025-07-20
Chief Tech/Sci/R&D Officer - 2020-06-29
Director TitleAgeSince
Director/Board Member - 2021-08-09
Chairman 67 2025-03-31
Director/Board Member 46 2025-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 7.58M
-2.48%-4.71%-35.29%-7.59% 29.98B
-6.53%-16.35%-49.96%+141.95% 12.68B
-1.73%-4.44%-25.85%+58.34% 5.41B
-4.76%-11.08% - - 2.09B
-2.32%-12.73%+44.59%-35.33% 1.86B
-3.41%-1.21% - - 1.78B
+0.58%-4.64%-36.65% - 1.05B
-4.20%-5.04%+37.46%+99.54% 855M
-2.10%-6.32%-41.89%-56.65% 746M
Average -2.04%-6.55%-15.37%+33.38% 6.27B
Weighted average by Cap. -3.39%-6.18%-33.97%+36.19%

Financials

2024 2025
Net sales 122M 85.44M 74.86M 69.5M 63.86M 120M 8.24B 828M 324M 4.03B 321M 314M 13.94B 62.99M 44.08M 38.62M 35.85M 32.95M 62.08M 4.25B 427M 167M 2.08B 165M 162M 7.19B
Net income 792K 554K 486K 451K 414K 781K 53.48M 5.37M 2.1M 26.17M 2.08M 2.04M 90.4M -60.21M -42.13M -36.91M -34.27M -31.49M -59.34M -4.07B -408M -160M -1.99B -158M -155M -6.87B
Net Debt -2.97M -2.08M -1.82M -1.69M -1.55M -2.93M -201M -20.14M -7.88M -98.15M -7.8M -7.64M -339M 7.09M 4.96M 4.35M 4.04M 3.71M 6.99M 479M 48.09M 18.82M 234M 18.63M 18.23M 809M
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-